1Bergwitz C, Collins MT, Kamath RS, et al. Case 33-2011: A56-year-old man with hypophosphatemia [J]. N Engl J Med,2011,365(17): 1625-1635.
2Woo VL, Landesberg R, Imel EA, et al. Phosphaturic mesenchy?mal tumor, mixed connective tissue variant, of the mandible: re?port of a case and review of the literature[J]. Oral Surg Oral MedOral Pathol Oral Radiol Endod,2009, 108(6): 925-932.
3Mc Cance RA. Osteomalacia with Looser's nodes (Milkman's syn?drome) due to a raised resistance to vitamin D acquired about theage of 15 years [J]. Q J Med,1947,16(1): 33-46.
6Nusier MK, Radaideh AR, Jaradat D, et al. Resolution of severeoncogenic hypophosphatemic osteomalacia after resection of a deep?ly located soft-tissue tumor[J]. Curr Oncol,2009, 16(5): 87-90.
6McCance RA. Osteomalacia with Looser's nodes (Milkman'syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years. Q J Med,1947,16:33-47.
7Cai Q, Hodgson SF, Kao PC, et al. Inhibition of renal phosphate transort by a tumor product in a patient with oncogenic osteomalacia. N Engl J Med, 1994,330 : 1645-1649.
8Bemdt TJ, Schiavi S, Kumar R. "Phosphatonins" and the regulation of phosphorus homeostasis. Am J Physiol Renal Physiol,2005,289: 1170-1182.
9Jonnson KB, Zahraadnik R, Larsson T, et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med,2003,348 : 1656-1663.
10Shimada T, Urakawa I, Yamazaki Y, et al. FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type Ⅱ a. Biochem Biophys Res Commun, 2004,314:409-414.
